SCID Mice Reconstituted with IL-4-Deficient Lymphocytes, but Not Immunocompetent Lymphocytes, Are Resistant to Cutaneous Leishmaniasis

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 5005-5013

  Satoskar, Abhay ^a,b   Brombacher, Frank ^c   Dai, Wen J ^c   McInnes, Ian ^d   Liew, Foo Y ^d   Alexander, James ^b   Walker, William ^b,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; NITRIC OXIDE SYNTHASE; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; LEISHMANIA MEXICANA; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PARASITOLOGY; PATHOLOGY; SKIN LEISHMANIASIS; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSPLANTATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELLS, CULTURED; IMMUNITY, NATURAL; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID; NITRIC OXIDE SYNTHASE; SPLEEN;

EID: 0031573080     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser and M. K. Gatley. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
2. Sypek, J. P., C. L. Chung, S. H. E. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
3. Afonso, L. C. C., T. M. Scharton, L. Q. Vierira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
4. Murray, H. W., J. Hariprashad, B. Aguero, T. Arakawa, and H. Yeganegi. 1995. Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice. J. Infect. Dis. 171:1309.
5. Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 32:161.
6. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
7. + subsets in experimental cutaneous leishmaniasis. Res. Immunol. 42:32.
8. Belosevic, M., D. L. Finbloom, P. H. van der Meide, M. V. Slayter, and C. Nacy. 1989. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/He mice to infection with Leishmania major. J. Immunol. 143:266.
9. Satoskar, A., and J. Alexander. 1995. Sex-determined susceptibility and differential IFN-γ and TNF-α mRNA expression in DBA/2 mice infected with Leishmania mexicana. Immunology 84:1.
10. Liew, F. Y., S. Millot, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasites in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794.
11. Evans, T., L. Thai, D. L. Granger, and J. B. Hibbs, Jr. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151: 907.
12. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffmann, and R. M. Locksley. 1989. Reciprocal expression of interferon-gamma or interleukin-4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
13. + subsets during murine Leishmania major infection. Res. Immunol. 142:28.
14. Afonso, L. C. C., and P. Scott. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61:2952.
15. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182.
16. Kaye, P. M., A. J. Curry, and J. M. Blackwell. 1991. Differential production of Th1 and Th2-derived cytokines does not determine the genetically controlled or vaccine induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146: 2763.
17. Guler, M. L., J. D. Gorham, C. S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271:984.
18. D'Andrea A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10(IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
19. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O'Gara, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukin 4 and 10 in an alpha beta T cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89:6065.
20. + T cells in a TH2 response and in immunoglobulin E production. Science 270:1845.
21. Seder, R. A., W. E. Paul, A. M. Dvorak, S. J. Sharkis, A. Kagey-Sobotka, Y. Niv, F. D. Finkelman, S. A. Barbieri, S. J. Galli, and M. Plaut. 1991. Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc. Natl. Acad. Sci. USA 88:2835.
22. Bradding, P., I. H. Feather, P. H. Howarth, R. Mueller, J. A. Roberts, K. Britten, J. P. Bews, T. C. Hunt, Y. Okayama, and C. H. Heusser. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381.
23. Brunner, T., C. H. Heusser, and C. A. Dahinden. 1993. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177:605.
24. Satoskar, A., H. Bluethmann, and J. Alexander. 1995. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 63:4894.
25. Noben Trauth, N., P. Kopf, and I. Muller. 1996. Susceptibility to Leishmania major in interleukin-4-deficient mice. Science 271:987.
26. Hart, D. T., K. Vickerman, and G. H. Coombs. 1981. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology 82: 345.
27. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
28. Chomszynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
29. Bouaboula, M., P. Legoux, B. Pessegue, B. Delpech, X. Dumont, M. Piechaczyk, P. Casellas, and D. Shire. 1992. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J. Biol. Chem. 267:21830.
30. Gilliland, G. S., S. Perrin, K. Blanchard, and H. F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:2725.
31. Shire, D. 1993. Open exchange of reagents and information useful for the measurement of cytokine mRNA levels by PCR. Eur. Cytokine Netw. 4:161.
32. Kopf, M., F. Brombacher, G. Kohler, G. Kienzle, K.-H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4 deficient mice resist infection with Leishmania major. J. Exp. Med. 184:1127.
33. Bancroft, G. J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5:503.
34. Leal, L. M., D. W. Moss, R. Kuhn, W. Muller, and F. Y. Liew. 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major. Eur. J. Immunol. 23:566.
35. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515.
36. + T cells during initiation of infection. J. Exp. Med. 179:447.
37. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263.
38. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Matliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
39. Kaye, P. M., N. J. Rogers, A. J. Curry, and J. C. Scott. 1994. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol. 24:2850.
40. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275.
41. Von-der-Weid, T., M. Kopf, G. Kohler, and J. Langhorne. 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 224:2285.
42. Brewer, J., M. Connacher, A. Satoskar, H. Bluethmann, and J. Alexander. 1996. In IL-4 deficient mice, alum not only generates Th1 responses equivalent to Freund's complete adjuvant, but also continues to induce Th2-type cytokine production. Eur. J. Immunol. 26:2062.
43. Liew, F. Y., Y. Li, A. Severn, S. Millot, J. Schimdt, M. Salter, and S. Moncada. 1991. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21:2489.
44. Liew, F. Y., S. Millott, Y. Li, R. Lelchuk, W. L. Chan, and H. Ziltenger. 1989. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)-3 and IL-4 produced by disease promoting T cells in leishmaniasis. Eur. J. Immunol. 19:1227.
45. 2 production and anti-leishmanial capacity of human cultured monocytes mediated by by IFN-gamma. J. Immunol. 143:3020.
46. + T cells from alpha beta TCR transgenic mice: IL-12 substitution from macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int. Immunol. 5:1119.
47. + T cells. J. Immunol. 154:5071.
48. Blank, C., H. Fuchs, K. Rappersberger, M. Rollinghoff, and H. Moll. 1993. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J. Infect. Dis. 167:418.
49. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430.
50. Lukacs, N. W., and D. L. Boros. 1993. Lymphokine regulation of granuloma formation in murine schistosomiasis mansoni. Clin. Immunol. Immunopathol. 68: 57.
51. -. Eur. J. Immunol. 25:3298.
52. + cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 155:4844.
53. Lezama-Davila, C. M., D. M. Williams, G. Gallagher, and J. Alexander. 1992. Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependent. Parasite Immunol. 14:37.
54. Bogdan, C., A. Gessner, W. Solbach, and M. Rollinghoff. 1996. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:517.
55. Varkila, K., R. Chatelaine, L. M. C. C. Leal, and R. L. Coffman. 1993. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur. J. Immunol. 23:262.
56. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
57. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
58. Aebischer, T., S. F. Moody, and E. Handman. 1993. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61:220.
59. Gramiccia, M., L. Gradoni, and M. Troiani. 1992. HIV-Leishmania co-infections in Italy: isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients. Trans. R. Soc. Trop. Med. Hyg. 86:161.
60. Gray, D., and P. Matzinger. 1991. T cell memory is short-lived in the absence of antigen. J. Exp. Med. 174:969.
61. Nakajima, H., G. J. Gleich, and H. Kita. 1996. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 156:4859.
62. Moller, G. M., T. A. de Jong, T. H. van der Kwast, S. E. Overbeek, A. F. Wierenga-Wolf, T. Thepen, and H. C. Hoongstanden. 1996. Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 14:439.
63. Wershil, B. K., C. M. Theodas, S. J. Galli, and R. G. Titus. 1994. Mast cells augment lesion size and persistence during experimental Leishmania major infection in mouse. J. Immunol. 152:4563.
64. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171:115.
65. + T-cell subsets in vivo. Immunol. Rev. 123:189.
66. Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
67. Hsieh, C. S., S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713.
68. Shankar, A. H., and R. G. Titus. 1995. T cell and non-T cell compartments can independently determine resistance to Leishmania major. J. Exp. Med. 181:845.
69. Alexander, J., and J. M. Blackwell. 1986. The immunological significance of genetically determined cross reactivity between taxonomically distinct Leishmania species. In Leishmania: Taxonomie et Phylogenese. IMEEE. Montpellier, pp. 185-191.
70. Roberts, M. B., J. Alexander, and J. M. Blackwell. 1989. Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice. Infect. Immun. 57:875.